ABSTRACTS -Myocardial Ischemia and Infarction 373A POSTER SESSION effected by locally delivering a cardioprotective peptide(dVl-1) in a clinically relevant model, after the ischemic event. These results might shed light onto a pharmacological strategy for the treatment of patients with acute myocardial infarction.
Trimetazidine
(TMZ) was reported to protect myocardium from ischemia by mechanisms not fully understood.
To better understand them, we used an ex-viva model of global myocardlal ischemla, perfused in a Langendorf apparatus. Thirty Wistar rat hearts were divided in 3 groups: A -180 minutes of perfusion with a modified Krebs solution, 6 60 minutes of p&won with the same solution. followed by 120 minutes of ischemia, in the absence of glucose and 0, and C -as in 8, but in the presence of TMZ 25 @ M. Mitochondria were then isolated and used to determine the activity of complexes I, II-111 and IV of the mitochondrial respiratory chain (MRC In conclusion, TMZ improved the efficiency of the oxidative system, with a better preservation of the electrochemical gradient within the inner mitochondrial membrane. It is for the first time shown that these mechanisms, involved in the cardioprotective effect of TMZ, are dependent on an increase in Complex I activity. Protein profiles were generated by two-dimensional electrophoresis (2-DE) and mass spectrometry to identify differentially expressed protams. Results: Rate pressure product (RPP, % baseline) at the end of the protocol was impaired in 151/60R (61+/-6 %, pcO.01) compared to control, consistent with stunning. In contrast. RPP was preserved in the MPG protected hearts (106+/-9 %, NS). Comparative analysis revealed 37 differences (> 2-fold difference in expression) from 5 functional groups (sarcomeric, cytoskeletal, mitochondrial, redox regulation and ion transport).
These differences may be the result of post translational modifications, for instance frag mentation. The modifications to myosin light chain-2. alpha actinin and Na/K ATPase were reversed by the addition of MPG. Conclusion:
The molecular mechanism of stunning is most likely a multifactorial process, involving damage to and /or alteration of several key protein systems. This study shows that scavenging of OFR results in the amelioration of some of these modifications. studied with respect to their differential effects on microvascular and myocardial salvage. Methods:
1145-103

Powerful Microvascular and Myocardial Protection by
NadH+-Exchange Inhibition and lschemic Preconditioning: Evidence for a Causal Link in the Rabbit
Infarct size (IS, triphenyltetrazolium) (% risk area (RA, blue dye)) was related to anatomic no-reflow (ANR, thioflavin S injection at the end of reperfusion), and regional myocardial blood flow (RMBF, radioactive microspheres, 30 and 180 min of reperiusion) in 52 anesthetized rabbits (30 min coronary occlusion, 180 min reparfusion). Results:
PC and Cp prior to occlusion (protocol 1) markedly reduced IS (by 40%, 62%", raspectively) and ANR (by 34% ', 53% "), which was accompanied by increased RMBF with both treatments. However, neither intervention uncoupled the close relationship (r=0.92-0.95) between IS and ANR, nor between IS and blood flow (ANCOVA). Importantly, Cp,
given 5 min before reperiusion (protocol 2). did not alter IS, ANR, RMBF or their close interrelationship.
Conclusions:
Despite pronounced microvascular and myocardial protection, neither intervention uncoupled the close correlation between ANR and IS, suggestlng a causal link between myocardial and microvascular salvage. cp<o.o5, "pc0.01) 0 20 20 4,, IS(% RA)
